XRTX - XORTX Therapeutics receives Nasdaq notice for non-compliance
2025-04-18 02:45:56 ET
Late stage clinical pharmaceutical company XORTX Therapeutics ( NASDAQ: XRTX ) received notification from the Nasdaq that it is not in compliance with the minimum bid price requirement since the closing bid price for the company's common shares listed on Nasdaq was below US$1.00 for 30 consecutive business days....
XORTX Therapeutics receives Nasdaq notice for non-compliance